MedTrace Logo

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

NCT01038258 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2012-07-13

No results posted yet for this study

Summary

A PET scan drop less than 20% in SUVs or below a certain absolute SUV value after the first course of neoadjuvant chemotherapy can predict pathological response, and could in the future lead to an early surgical intervention.

Conditions

  • Invasive Ductal Carcinoma
  • Lobular Breast Carcinoma
  • Inflammatory Breast Carcinoma

Interventions

PROCEDURE

PET scan after course 1 and surgery after 8 courses

PET scan and surgery

Sponsors & Collaborators

  • Sononuclear

    collaborator UNKNOWN

  • Auxilio Mutuo Cancer Center

    lead OTHER

Principal Investigators

  • Fernando Cabanillas, MD · Hospital Auxilio Mutuo Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-12-31
Completion
2013-04-30

Countries

  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01038258 on ClinicalTrials.gov